半岛bd体育手机客户端 说明
一般描述
An anti-neoplastic, anti-angiogenic agent that uncouples G-proteins from receptors presumably by blocking their interaction with intracellular receptor domains. A competitive inhibitor of reverse transcriptase. Reported to inhibit topoisomerase I and II. Inhibits Ca2+-ATPase in sarcoplasmic reticulum membranes. Also inhibits the cell-surface binding of various growth factors including EGF, PDGF, and TGF-β. An inhibitor of phospholipase D (IC50= 15 ?M). Reported to interact with ATP-binding enzymes and P2-purinergic receptors. An effective inhibitor of angiogenesis in calmodulin assays when given in combination with angiostatic steroids.
A reversible and competitive inhibitor of protein tyrosine phosphatases. An anti-neoplastic, anti-angiogenic agent that uncouples G-proteins from receptors presumably by blocking their interaction with intracellular receptor domains. Inhibits GDP-GTP exchange, the rate limiting step in the activation of Gα-subunits. A competitive inhibitor of reverse transcriptase. Reported to inhibit topoisomerases I and II. Inhibits Ca2+-ATPase in sarcoplasmic reticulum membranes. Also inhibits the cell-surface binding of various growth factors, including EGF, PDGF, and TGF-β. An inhibitor of phospholipase D (IC50= 15 ?M). Reported to interact with ATP-binding enzymes and P2-purinergic receptors. An effective inhibitor of angiogenesis in the calmodulin assay when given in combination with angiostatic steroids.
包装
50 mg in Plastic ampoule
生化/生理作用
Primary Target
protein tyrosine phosphatases
Target IC50: 15 ?M against phospholipase D
Product does not compete with ATP.
Cell permeable: no
Reversible: yes
警告
Toxicity: Standard Handling (A)
重悬
Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 1 month at -20°C.
其他说明
Meyers, M.O., et al. 2000.J. Surg. Res.91,130.
Hohenegger, M., et al. 1998.Proc. Natl. Acad. Sci. USA95,346.
Waldhoer, M., et al. 1998.Mol. Pharmacol.53,808.
Zhang, Y.L., et al. 1998.J. Biol. Chem.273,12281.
Hohenegger, M., et al. 1996.Mol. Pharmacol.50,1443.
Emmick, J.J., et al. 1994.J. Pharmacol. Exp. Ther.269,717.
Denhertog, A., et al. 1992.J. Physiol.454,591.
Nakajima, M., et al. 1991.J. Biol. Chem.266,9661.
Wilks, J.W., et al. 1991.Int. J. Radiat. Biol.60,73.
Huang, R.C., et al. 1990.Mol. Pharmacol.37,304.
Kopp, R. and Pfeiffer, A. 1990.Cancer Res.50,6490.
法律信息
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
基本信息
| 经验(实验)分子式 | C51H34N6O23S6· 6Na |
| 分子量 | 1429.17 |
| MDL编号 | MFCD00210217 |
半岛bd体育手机客户端 性质
| 质量水平 | 100 |
| 测定 | ≥98% (HPLC) |
| 形式 | crystalline solid |
| manufacturer/tradename | Calbiochem? |
| 储存条件 | OK to freeze desiccated (hygroscopic) |
| 颜色 | white |
| 溶解性 | water: 5 mg/mL |
| 运输 | ambient |
| 储存温度 | 2-8℃ |
| InChI | 1S/C51H40N6O23S6.6Na/c1-25-9-11-29(49(60)54-37-13-15-41(83(69,70)71)35-21-33(81(63,64)65)23-43(45(35)37)85(75,76)77)19-39(25)56-47(58)27-5-3-7-31(17-27)52-51(62)53-32-8-4-6-28(18-32)48(59)57-40-20-30(12-10-26(40)2)50(61)55-38-14-16-42(84(72,73)74)36-22-34(82(66,67)68)24-44(46(36)38)86(78,79)80;;;;;;/h3-24H,1-2H3,(H,54,60)(H,55,61)(H,56,58)(H,57,59)(H2,52,53,62)(H,63,64,65)(H,66,67,68)(H,69,70,71)(H,72,73,74)(H,75,76,77)(H,78,79,80);;;;;;/q;6*+1/p-6 |
| InChI key | VAPNKLKDKUDFHK-UHFFFAOYSA-H |
安全信息
| 储存分类代码 | 11 - Combustible Solids |
| WGK | WGK 3 |
| 闪点(F) | Not applicable |
| 闪点(C) | Not applicable |
Sigma-Aldrich
m.cnreagent.com
